Pacific Biosciences of California, Inc. (PACB)
1.28
-0.07
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
1.32
+0.04
(+3.12%)
After-Hours: 05:31
Pacific Biosciences of California Total Assets (Quarterly) : 751.85M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 751.85M |
| March 31, 2026 | 782.36M |
| December 31, 2025 | 784.08M |
| September 30, 2025 | 803.16M |
| June 30, 2025 | 825.47M |
| March 31, 2025 | 860.79M |
| December 31, 2024 | 1.260B |
| September 30, 2024 | 1.450B |
| June 30, 2024 | 1.509B |
| March 31, 2024 | 1.670B |
| December 31, 2023 | 1.746B |
| September 30, 2023 | 1.898B |
| June 30, 2023 | 1.848B |
| March 31, 2023 | 1.896B |
| December 31, 2022 | 1.767B |
| September 30, 2022 | 1.819B |
| June 30, 2022 | 1.876B |
| March 31, 2022 | 1.937B |
| December 31, 2021 | 2.007B |
| September 30, 2021 | 2.034B |
| June 30, 2021 | 1.246B |
| March 31, 2021 | 1.253B |
| December 31, 2020 | 413.98M |
| September 30, 2020 | 300.32M |
| June 30, 2020 | 213.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 234.76M |
| December 31, 2019 | 147.98M |
| September 30, 2019 | 146.11M |
| June 30, 2019 | 170.58M |
| March 31, 2019 | 185.58M |
| December 31, 2018 | 170.28M |
| September 30, 2018 | 182.91M |
| June 30, 2018 | 137.06M |
| March 31, 2018 | 156.95M |
| December 31, 2017 | 144.08M |
| September 30, 2017 | 157.90M |
| June 30, 2017 | 177.90M |
| March 31, 2017 | 135.51M |
| December 31, 2016 | 137.88M |
| September 30, 2016 | 150.64M |
| June 30, 2016 | 161.37M |
| March 31, 2016 | 140.18M |
| December 31, 2015 | 131.11M |
| September 30, 2015 | 99.78M |
| June 30, 2015 | 96.77M |
| March 31, 2015 | 106.42M |
| December 31, 2014 | 124.52M |
| September 30, 2014 | 121.64M |
| June 30, 2014 | 128.24M |
| March 31, 2014 | 141.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Illumina, Inc. | 6.65B |
| Agilent Technologies, Inc. | 13.06B |
| Bio-Rad Laboratories, Inc. | 10.25B |
| Danaher Corp. | 92.37B |
| Thermo Fisher Scientific, Inc. | 113.17B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 785.06M |
| Shareholders Equity (Quarterly) | -33.21M |
| Debt to Equity Ratio | -21.26 |
| Current Ratio | 4.922 |
| Net Debt Paydown Yield | -0.27% |